deferasirox has been researched along with Pregnancy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonucci, R; Asara, MA; Caggiari, S; Capobianco, G; Dessole, S; Dore, F; Fozza, C; Monti, A; Vacca, N; Zaccheddu, F | 1 |
| El Rassi, F; Saliba, AN; Taher, AT | 1 |
| Agapidou, A; Diamantidis, MD; Fotiou, P; Manafas, A; Neokleous, N; Vetsiou, E; Vlachaki, E | 1 |
| Boernsen, KO; Bruin, GJ; Faller, T; Nick, H; Schneider, J; Schweitzer, A; Waldmeier, F; Wiegand, H | 1 |
| Drosou, M; Servos, P; Vini, D | 1 |
| Cinque, P; Costantini, S; Di Matola, T; Prossomariti, L; Ricchi, P; Spasiano, A | 1 |
| Abbate, G; Anastasi, S; Caruso, V; De Sanctis, V; Giovannini, M; Lisi, R | 1 |
1 review(s) available for deferasirox and Pregnancy
| Article | Year |
|---|---|
Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.
Topics: Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Disease Management; Drug-Related Side Effects and Adverse Reactions; Female; Ferritins; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Magnetic Resonance Imaging; Male; Myocardium; Pregnancy; Pyridones; Triazoles | 2016 |
6 other study(ies) available for deferasirox and Pregnancy
| Article | Year |
|---|---|
Pregnancy Outcome among Women with Beta-Thalassemia Major in North Sardinia.
Topics: Abortion, Spontaneous; Adult; Benzoates; beta-Thalassemia; Deferasirox; Deferoxamine; Diabetes, Gestational; Female; Fetal Growth Retardation; Humans; Iron Chelating Agents; Italy; Pregnancy; Pregnancy Outcome; Premature Birth; Triazoles | 2017 |
Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?
Topics: Adult; Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Female; Fetus; Humans; Infant, Newborn; Iron Chelating Agents; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Pyridones; Triazoles | 2016 |
Pharmacokinetics, distribution, metabolism, and excretion of deferasirox and its iron complex in rats.
Topics: Animals; Animals, Suckling; ATP-Binding Cassette Transporters; Benzoates; Bile; Blood Chemical Analysis; Deferasirox; Enterohepatic Circulation; Feces; Female; Fetus; Iron; Iron Chelating Agents; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Milk, Human; Models, Biological; Molecular Structure; Placenta; Pregnancy; Rats; Rats, Long-Evans; Rats, Transgenic; Rats, Wistar; Tissue Distribution; Triazoles; Urine | 2008 |
Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®).
Topics: Adult; Benzoates; beta-Thalassemia; Contraindications; Deferasirox; Female; Humans; Infant, Newborn; Iron Chelating Agents; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Triazoles | 2011 |
A case of well-tolerated and safe deferasirox administration during the first trimester of a spontaneous pregnancy in an advanced maternal age thalassemic patient.
Topics: Administration, Oral; Adult; Benzoates; beta-Thalassemia; Deferasirox; Female; Humans; Iron Chelating Agents; Maternal Age; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Pregnancy Trimester, First; Triazoles | 2011 |
Absence of teratogenicity of deferasirox treatment during pregnancy in a thalassaemic patient.
Topics: Adult; Benzoates; beta-Thalassemia; Deferasirox; Female; Humans; Infant, Newborn; Iron Chelating Agents; Male; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Teratogens; Triazoles | 2011 |